Funder
GlaxoSmithKline Biologicals SA
PATH Malaria Vaccine Initiative
Catalan Government
Spanish Government
Medicines for Malaria Venture
Bill & Melinda Gates Foundation
MVI
GlaxoSmithKline
Malaria Clinical Trial Alliance
GSK Biologicals SA
PATH MVI
Reference16 articles.
1. World Malaria Report, 2014,2014
2. Safety, immunogenicity, and efficacy of a recombinantly produced Plasmodium falciparum circumsporozoite protein-hepatitis B surface antigen subunit vaccine;Gordon;J Infect Dis,1995
3. From the circumsporozoite protein to the RTS,S/AS candidate vaccine;Cohen;Hum Vacc,2010
4. Randomized, double-blind, phase 2a trial of falciparum malaria vaccines RTS,S/AS01B and RTS,S/AS02A in malaria-naive adults: safety, efficacy, and immunologic associates of protection;Kester;J Infect Dis,2009
5. A randomized trial assessing the safety and immunogenicity of AS01 and AS02 adjuvanted RTS,S malaria vaccine candidates in children in Gabon;Lell;PLoS One,2009
Cited by
1172 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献